Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Verapamil
Drug ID BADD_D02348
Description Verapamil is a phenylalkylamine calcium channel blocker used in the treatment of high blood pressure, heart arrhythmias, and angina,[L8791] and was the first calcium channel antagonist to be introduced into therapy in the early 1960s.[A188514] It is a member of the non-dihydropyridine class of calcium channel blockers, which includes drugs like [diltiazem] and [flunarizine], but is chemically unrelated to other cardioactive medications.[L8791] Verapamil is administered as a racemic mixture containing equal amounts of the S- and R-enantiomer, each of which is pharmacologically distinct - the S-enantiomer carries approximately 20-fold greater potency than the R-enantiomer, but is metabolized at a higher rate.[A188435]
Indications and Usage Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal's) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter.[L8791] Given intravenously, it is indicated for the treatment of various supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm in patients with supraventricular tachycardia and for temporary control of ventricular rate in patients with atrial fibrillation or atrial flutter.[L10481] Verapamil is commonly used off-label for prophylaxis of cluster headaches.[A13983]
Marketing Status approved
ATC Code C08DA01
DrugBank ID DB00661
KEGG ID D02356
MeSH ID D014700
PubChem ID 2520
TTD Drug ID D0R0FE
NDC Product Code 70966-0029
UNII CJ0O37KU29
Synonyms Verapamil | Iproveratril | Cordilox | Dexverapamil | Verapamil Hydrochloride | Hydrochloride, Verapamil | Finoptin | Izoptin | Isoptine | Isoptin | Lekoptin | Calan | Falicard
Chemical Information
Molecular Formula C27H38N2O4
CAS Registry Number 52-53-9
SMILES CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperhidrosis23.02.03.004; 08.01.03.0280.000267%
Hyperkalaemia14.05.03.0010.000198%
Hyperkeratosis23.01.01.001--
Hyperkinesia17.01.02.008--Not Available
Hyperprolactinaemia05.03.01.002--Not Available
Hypersensitivity10.01.03.0030.000099%
Hypertension24.08.02.0010.000218%
Hypertrophic cardiomyopathy03.07.07.005; 02.04.01.002--Not Available
Hypoaesthesia23.03.03.081; 17.02.06.023--Not Available
Hypocalcaemia14.04.01.0040.000099%
Hypoglycaemia05.06.03.001; 14.06.03.0010.000148%
Hypomagnesaemia14.04.02.0010.000099%
Hypotension24.06.03.0020.002867%
Hypoxia22.02.02.0030.000395%
Ileus07.13.01.001--
Ileus paralytic07.02.05.001--Not Available
Infection11.01.08.002--Not Available
Influenza11.05.03.001; 22.07.02.001--Not Available
Injury12.01.08.004--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Intermittent claudication24.04.03.001--Not Available
Jaundice09.01.01.004; 01.06.04.004; 23.03.03.030--Not Available
Joint swelling15.01.02.004--Not Available
Lactic acidosis14.01.01.0020.000297%Not Available
Laryngospasm22.04.02.002--
Lethargy19.04.04.004; 08.01.01.008; 17.02.04.0030.000297%
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.0050.000099%Not Available
Loss of consciousness17.02.04.004--Not Available
Macular oedema06.04.06.005--Not Available
Macule23.03.03.037--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene